Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
出版信息
Dis Markers. 1991 Jan-Feb;9(1):51.
PMID:1742945
Abstract
摘要
相似文献
1
2
Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection.非保护性疫苗接种对后续人类免疫缺陷病毒感染抗体反应的影响。
J Clin Invest. 1994 Jan;93(1):140-6. doi: 10.1172/JCI116937.
3
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
Nature. 1990 Jun 14;345(6276):622-5. doi: 10.1038/345622a0.
4
5
Positive response. Encouraging results in the search for an AIDS vaccine.
Sci Am. 1991 Aug;265(2):26.
6
Human trials of AIDS vaccines: current status and future directions.艾滋病疫苗的人体试验：现状与未来方向。
AIDS. 1989;3 Suppl 1:S125-9.
7
Two additional AIDS vaccines approved for clinical trials.
J Am Osteopath Assoc. 1991 May;91(5):433.
8
HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. Clin Exp Immun 1994;98:178-84.以加速剂量方案接种的HIV-1重组gp160疫苗。《临床与实验免疫学》1994年；98:178 - 184。
Pediatr AIDS HIV Infect. 1995 Apr;6(2):97-8.
9
HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees.HIV-1包膜诱导的中和抗体滴度与黑猩猩的保护作用及病毒载量相关。
Vaccine. 1994 Sep;12(12):1141-8. doi: 10.1016/0264-410x(94)90185-6.
Zotero 插件